| RS111033827 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS111033829 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS111033831 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS111033832 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS111033836 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS111033838 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS111033848 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS111033849 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1110400 |
MC1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma, cutaneous malignant |
| RS11104729 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 14, Joubert syndrome 5 |
| RS111052004 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS111060773 |
OTC
|
Health Risk |
Pathogenic |
— |
| RS111060774 |
OTC
|
Health Risk |
Pathogenic |
— |
| RS1110991 |
ACE
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, ACE-related disorder |
| RS111113624 |
ABCC6
|
Health Risk |
Pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Pseudoxanthoma elasticum |
| RS111113625 |
ABCC6
|
Health Risk |
Likely pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS111231312 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS111231879 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS111239111 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS111241046 |
GPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS111243479 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS111246617 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS111247323 |
L1CAM
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS111248269 |
TMEM70
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 |
| RS111250144 |
DNAAF3-AS1;TNNI3;DNAAF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Hypertrophic cardiomyopathy 7 |
| RS111250264 |
CHD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS111254723 |
PMS1
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS11125529 |
ACYP2
|
Health Risk |
association |
Chronic osteomyelitis, Chronic osteomyelitis |
| RS111256477 |
GRHPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria, type II |
| RS111256741 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS111256750 |
CTNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Ocular cystinosis, Nephropathic cystinosis |
| RS111257462 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS111262307 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS111262341 |
GREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial colorectal cancer, Hereditary cancer-predisposing syndrome |
| RS111265848 |
FSIP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111266450 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS111266804 |
ATP2A1
|
Health Risk |
Likely pathogenic |
Brody myopathy, Brody myopathy |
| RS111270711 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Foveal hypoplasia 1, Anophthalmia-microphthalmia syndrome |
| RS111271660 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS111280997 |
APC2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111281600 |
CENPE
|
Health Risk |
Conflicting classifications of pathogenicity |
CENPE-related disorder, CENPE-related disorder |
| RS111282958 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111283999 |
GATA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypoparathyroidism, deafness |
| RS111286066 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Inborn genetic diseases |
| RS111286659 |
PEX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 2A (Zellweger), Peroxisome biogenesis disorder 2B |
| RS111288905 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS111290936 |
EIF4G1
|
Health Risk |
risk factor |
Parkinson disease 18, autosomal dominant |
| RS111291014 |
ALDH4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperprolinemia type 2, Hyperprolinemia type 2 |
| RS111293259 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy |
| RS111294855 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, Joubert syndrome 17 |
| RS111295967 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS111297226 |
ARPC1B
|
Health Risk |
Pathogenic |
Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease, Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease |
| RS111298318 |
KRT74
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111300270 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS111302956 |
GNE
|
Health Risk |
Pathogenic |
Sialuria, GNE myopathy |
| RS111306515 |
HSPG2
|
Health Risk |
Likely pathogenic |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome type 1 |
| RS111306749 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS111306884 |
FLNA
|
Health Risk |
Likely pathogenic |
Attenuated frontometaphyseal dysplasia, Attenuated frontometaphyseal dysplasia |
| RS11130760 |
FHIT
|
Health Risk |
association |
Lip and oral cavity carcinoma, Lip and oral cavity carcinoma |
| RS111312760 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS111313628 |
HMGCS2
|
Health Risk |
Pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS111314129 |
WNT10A
|
Health Risk |
Pathogenic/Likely pathogenic |
Tooth agenesis, selective |
| RS111315726 |
MKS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS111316318 |
NEK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Arthrogryposis, Perthes disease |
| RS111316898 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS111316957 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS111320552 |
TDRD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 36, Cataract 36 |
| RS111320759 |
MGP
|
Health Risk |
Pathogenic/Likely pathogenic |
Keutel syndrome, Keutel syndrome |
| RS111321293 |
NUBPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS111324750 |
FLNC
|
Health Risk |
Likely pathogenic |
Distal myopathy with posterior leg and anterior hand involvement, Hypertrophic cardiomyopathy 26 |
| RS111325146 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS111327589 |
CFHR5
|
Health Risk |
Conflicting classifications of pathogenicity |
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS111331642 |
ARHGDIA
|
Health Risk |
Conflicting classifications of pathogenicity |
ARHGDIA-related disorder, ARHGDIA-related disorder |
| RS111341650 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS111342797 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani syndrome, Glaucoma 3 |
| RS111344340 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 12, Naxos disease |
| RS111344408 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial dilated cardiomyopathy, Cardiomyopathy |
| RS111347025 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis |
| RS111347361 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS111353791 |
MANBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS111356679 |
TFG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary motor and sensory neuropathy, Okinawa type |
| RS111358560 |
BBS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS111360822 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, COL7A1-related disorder |
| RS111360923 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, LRP2-related disorder |
| RS111363334 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Inborn genetic diseases |
| RS111364296 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS111364670 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS111366222 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS111367233 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS111367604 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS111368396 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS111369573 |
PSAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Gaucher disease due to saposin C deficiency, Krabbe disease due to saposin A deficiency |
| RS111370546 |
IL7R
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 104, Immunodeficiency 104 |
| RS111370716 |
RYR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS111371929 |
TMEM216
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 2, Meckel syndrome |
| RS111373423 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 10, MYL2-related disorder |
| RS111377893 |
TNNT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Dilated cardiomyopathy 1D |
| RS111379417 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS111380006 |
PCSK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity due to prohormone convertase I deficiency, Obesity due to prohormone convertase I deficiency |
| RS111381550 |
TRAPPC11
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |